{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:23:01Z","timestamp":1648729381227},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,28]],"date-time":"2011-08-28T00:00:00Z","timestamp":1314489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10238-011-0152-7","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T10:28:44Z","timestamp":1314440924000},"page":"135-143","source":"Crossref","is-referenced-by-count":2,"title":["VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors"],"prefix":"10.1007","volume":"12","author":[{"given":"Gui-shan","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-dong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,28]]},"reference":[{"key":"152_CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","volume":"129","author":"M Jmoudiak","year":"2005","unstructured":"Jmoudiak M, Futerman AH (2005) Gaucher disease: pathological mechanisms and modern management. Br J Haematol 129:178\u2013188","journal-title":"Br J Haematol"},{"key":"152_CR2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","volume":"113","author":"NJ Weinreb","year":"2002","unstructured":"Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Zimran A (2002) Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2\u20135\u00a0years of treatment: a report from the Gaucher Registry. Am J Med 113:112\u2013119","journal-title":"Am J Med"},{"key":"152_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jbspin.2007.06.006","volume":"75","author":"P Guggenbuhl","year":"2008","unstructured":"Guggenbuhl P, Grosbois B, Chales G (2008) Gaucher disease. Jt Bone Spine 75:116\u2013124","journal-title":"Jt Bone Spine"},{"key":"152_CR4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","volume":"324","author":"NW Barton","year":"1991","unstructured":"Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE, Et A (1991) Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease. N Engl J Med 324:1464\u20131470","journal-title":"N Engl J Med"},{"key":"152_CR5","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1073\/pnas.87.6.2334","volume":"87","author":"JK Fink","year":"1990","unstructured":"Fink JK, Correll PH, Perry LK, Brady RO, Karlsson S (1990) Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease. Proc Natl Acad Sci USA 87:2334\u20132338","journal-title":"Proc Natl Acad Sci USA"},{"key":"152_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/hum.1991.2.2-101","volume":"2","author":"DB Kohn","year":"1991","unstructured":"Kohn DB, Nolta JA, Weinthal J, Bahner I, Yu XJ, Lilley J, Crooks GM (1991) Toward gene therapy for Gaucher disease. Hum Gene Ther 2:101\u2013105","journal-title":"Hum Gene Ther"},{"key":"152_CR7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.V75.3.787.787","volume":"75","author":"JA Nolta","year":"1990","unstructured":"Nolta JA, Sender LS, Barranger JA, Kohn DB (1990) Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer. Blood 75:787\u2013797","journal-title":"Blood"},{"key":"152_CR8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1517\/14712598.1.5.857","volume":"1","author":"JM Barranger","year":"2001","unstructured":"Barranger JM, Novelli EA (2001) Gene therapy for lysosomal storage disorders. Expert Opin Biol Ther 1:857\u2013867","journal-title":"Expert Opin Biol Ther"},{"key":"152_CR9","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1089\/hum.1998.9.17-2629","volume":"9","author":"CE Dunbar","year":"1998","unstructured":"Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RV, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, Karlsson S (1998) Retroviral transfer of the glucocerebrosidase gene into CD34\u00a0+\u00a0cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther 9:2629\u20132640","journal-title":"Hum Gene Ther"},{"key":"152_CR10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/365666a0","volume":"365","author":"MI Bukrinsky","year":"1993","unstructured":"Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M (1993) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666\u2013669","journal-title":"Nature"},{"key":"152_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2004.04.040","volume":"318","author":"EY Kim","year":"2004","unstructured":"Kim EY, Hong YB, Lai Z, Kim HJ, Cho YH, Brady RO, Jung SC (2004) Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease. Biochem Biophys Res Commun 318:381\u2013390","journal-title":"Biochem Biophys Res Commun"},{"key":"152_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.gt.3301383","volume":"8","author":"KG Ford","year":"2001","unstructured":"Ford KG, Souberbielle BE, Darling D, Farzaneh F (2001) Protein transduction: an alternative to genetic intervention? Gene Ther 8:1\u20134","journal-title":"Gene Ther"},{"key":"152_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0092-8674(00)81843-7","volume":"88","author":"G Elliott","year":"1997","unstructured":"Elliott G, O\u2019Hare P (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88:223\u2013233","journal-title":"Cell"},{"key":"152_CR14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nbt0598-440","volume":"16","author":"A Phelan","year":"1998","unstructured":"Phelan A, Elliott G, O\u2019Hare P (1998) Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol 16:440\u2013443","journal-title":"Nat Biotechnol"},{"key":"152_CR15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.gt.3301904","volume":"10","author":"D Zavaglia","year":"2003","unstructured":"Zavaglia D, Favrot MC, Eymin B, Tenaud C, Coll JL (2003) Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein. Gene Ther 10:314\u2013325","journal-title":"Gene Ther"},{"key":"152_CR16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/gast.2002.34756","volume":"123","author":"L Zender","year":"2002","unstructured":"Zender L, Kock R, Eckhard M, Frericks B, Gosling T, Gebhardt T, Drobek S, Galanski M, Kuhnel F, Manns M, Kubicka S (2002) Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroenterology 123:608\u2013618","journal-title":"Gastroenterology"},{"key":"152_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/MCB.7.1.379","volume":"7","author":"RB DuBridge","year":"1987","unstructured":"DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7:379\u2013387","journal-title":"Mol Cell Biol"},{"key":"152_CR18","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1128\/JVI.72.11.8873-8883.1998","volume":"72","author":"H Mochizuki","year":"1998","unstructured":"Mochizuki H, Schwartz JP, Tanaka K, Brady RO, Reiser J (1998) High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 72:8873\u20138883","journal-title":"J Virol"},{"key":"152_CR19","doi-asserted-by":"crossref","first-page":"15266","DOI":"10.1073\/pnas.93.26.15266","volume":"93","author":"J Reiser","year":"1996","unstructured":"Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M (1996) Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A 93:15266\u201315271","journal-title":"Proc Natl Acad Sci U S A"},{"key":"152_CR20","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1128\/JVI.74.22.10589-10599.2000","volume":"74","author":"J Reiser","year":"2000","unstructured":"Reiser J, Lai Z, Zhang XY, Brady RO (2000) Development of multigene and regulated lentivirus vectors. J Virol 74:10589\u201310599","journal-title":"J Virol"},{"key":"152_CR21","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","volume":"90","author":"WS Pear","year":"1993","unstructured":"Pear WS, Nolan GP, Scott ML, Baltimore D (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90:8392\u20138396","journal-title":"Proc Natl Acad Sci U S A"},{"key":"152_CR22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.cb.05.110189.002411","volume":"5","author":"S Kornfeld","year":"1989","unstructured":"Kornfeld S, Mellman I (1989) The biogenesis of lysosomes. Annu Rev Cell Biol 5:483\u2013525","journal-title":"Annu Rev Cell Biol"},{"key":"152_CR23","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.87.5.1913","volume":"87","author":"NW Barton","year":"1990","unstructured":"Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO (1990) Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci USA 87:1913\u20131916","journal-title":"Proc Natl Acad Sci USA"},{"key":"152_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mthe.2002.0653","volume":"6","author":"TH Nguyen","year":"2002","unstructured":"Nguyen TH, Oberholzer J, Birraux J, Majno P, Morel P, Trono D (2002) Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther 6:199\u2013209","journal-title":"Mol Ther"},{"key":"152_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263\u2013267","journal-title":"Science"},{"key":"152_CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jnr.10137","volume":"67","author":"Z Lai","year":"2002","unstructured":"Lai Z, Brady RO (2002) Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector. J Neurosci Res 67:363\u2013371","journal-title":"J Neurosci Res"},{"key":"152_CR27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.gt.3300850","volume":"6","author":"G Elliott","year":"1999","unstructured":"Elliott G, O\u2019Hare P (1999) Intercellular trafficking of VP22-GFP fusion proteins. Gene Ther 6:149\u2013151","journal-title":"Gene Ther"},{"key":"152_CR28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nbt0102-20","volume":"20","author":"RP Bennett","year":"2002","unstructured":"Bennett RP, Dalby B, Guy PM (2002) Protein delivery using VP22. Nat Biotechnol 20:20","journal-title":"Nat Biotechnol"},{"key":"152_CR29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JVI.74.2.1051-1056.2000","volume":"74","author":"N Brewis","year":"2000","unstructured":"Brewis N, Phelan A, Webb J, Drew J, Elliott G, O\u2019Hare P (2000) Evaluation of VP22 spread in tissue culture. J Virol 74:1051\u20131056","journal-title":"J Virol"},{"key":"152_CR30","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1073\/pnas.122231699","volume":"99","author":"MT Sciortino","year":"2002","unstructured":"Sciortino MT, Taddeo B, Poon AP, Mastino A, Roizman B (2002) Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection. Proc Natl Acad Sci U S A 99:8318\u20138323","journal-title":"Proc Natl Acad Sci U S A"},{"key":"152_CR31","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/sj.gt.3301564","volume":"8","author":"WA Wybranietz","year":"2001","unstructured":"Wybranietz WA, Gross CD, Phelan A, O\u2019Hare P, Spiegel M, Graepler F, Bitzer M, Stahler P, Gregor M, Lauer UM (2001) Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther 8:1654\u20131664","journal-title":"Gene Ther"},{"key":"152_CR32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jgm.164","volume":"3","author":"CS Liu","year":"2001","unstructured":"Liu CS, Kong B, Xia HH, Ellem KA, Wei MQ (2001) VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. J Gene Med 3:145\u2013152","journal-title":"J Gene Med"},{"key":"152_CR33","doi-asserted-by":"crossref","first-page":"15042","DOI":"10.1074\/jbc.M010294200","volume":"276","author":"N Normand","year":"2001","unstructured":"Normand N, van Leeuwen H, O\u2019Hare P (2001) Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J Biol Chem 276:15042\u201315050","journal-title":"J Biol Chem"},{"key":"152_CR34","first-page":"3185","volume":"22","author":"I Roy","year":"2002","unstructured":"Roy I, Holle L, Song W, Holle E, Wagner T, Yu X (2002) Efficient translocation and apoptosis induction by adenovirus encoded VP22\u2013p53 fusion protein in human tumor cells in vitro. Anticancer Res 22:3185\u20133189","journal-title":"Anticancer Res"},{"key":"152_CR35","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1128\/JVI.75.18.8733-8741.2001","volume":"75","author":"KN Wills","year":"2001","unstructured":"Wills KN, Atencio IA, Avanzini JB, Neuteboom S, Phelan A, Philopena J, Sutjipto S, Vaillancourt MT, Wen SF, Ralston RO, Johnson DE (2001) Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. J Virol 75:8733\u20138741","journal-title":"J Virol"},{"key":"152_CR36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.cgt.7700465","volume":"9","author":"L Zender","year":"2002","unstructured":"Zender L, Kuhnel F, Kock R, Manns M, Kubicka S (2002) VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo. Cancer Gene Ther 9:489\u2013496","journal-title":"Cancer Gene Ther"},{"key":"152_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00109-003-0421-3","volume":"81","author":"L Boenicke","year":"2003","unstructured":"Boenicke L, Chu K, Pauls R, Tams C, Kruse ML, Kurdow R, Schniewind B, Bohle A, Kremer B, Kalthoff H (2003) Efficient dose-dependent and time-dependent protein transduction of pancreatic carcinoma cells in vitro and in vivo using purified VP22-EGFP fusion protein. J Mol Med 81:205\u2013213","journal-title":"J Mol Med"},{"key":"152_CR38","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(96)04451-0","volume":"348","author":"PK Mistry","year":"1996","unstructured":"Mistry PK, Wraight EP, Cox TM (1996) Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher\u2019s disease. Lancet 348:1555\u20131559","journal-title":"Lancet"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-011-0152-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-011-0152-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-011-0152-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T19:42:04Z","timestamp":1592854924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-011-0152-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,28]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1007\/s10238-011-0152-7","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,28]]}}}